NCT01194336View on ClinicalTrials.gov

Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Biomarkers, Pharmacological
Interventions
DRUG

Huperzine A

dosage form: tablet dose frequency: once only

DRUG

Donepezil

dosage form: tablet dosage frequency: once only

DRUG

Galantamine

dosage form: tablet dosage frequency: once only

OTHER

Placebo

dosage form: tablet dosage frequency: once only

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Silver Spring

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

U.S. Army Medical Research and Development Command

FED

NCT01194336 - Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance | Biotech Hunter | Biotech Hunter